| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.16 | 0.0009 |